Literature DB >> 4077238

Renal histopathology in hypertensive diabetic patients.

G Ditscherlein.   

Abstract

A total of 250 renal biopsy specimens from diabetic patients and from the kidneys of 400 autopsy cases were examined histologically and compared to kidneys from 160 autopsied nondiabetics. The morphological findings were assessed in relation to hypertension. There was a high prevalence of arteriolosclerosis, glomerulosclerosis, and pyelonephritis; in addition, early diabetic glomerulopathy and glomerulonephritis, particularly of the membranous type, were noted in a remarkably high percentage of diabetic patients. Ninety-three percent of patients with hypertension had arteriolosclerosis, and a good correlation existed between the extent of this lesion and the level of blood pressure. Even in 66% of normotensive patients, however, arteriolosclerosis was found. This fact and the involvement of the vas efferens argue against the notion of arteriolosclerosis being exclusively a sequela of hypertension. More than 70% of patients with glomerulosclerosis suffered from hypertension, compared to less than 50% of patients without either that condition or early diabetic lesions. The majority of diabetic patients with pyelonephritis and glomerulonephritis were hypertensive. We conclude that hypertension in diabetic patients with renal involvement may result from different renal lesions that can be differentiated only by histological examination.

Entities:  

Mesh:

Year:  1985        PMID: 4077238     DOI: 10.1161/01.hyp.7.6_pt_2.ii29

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  2 in total

1.  Age and Outcomes Associated with BP in Patients with Incident CKD.

Authors:  Csaba P Kovesdy; Ahmed Alrifai; Elvira O Gosmanova; Jun Ling Lu; Robert B Canada; Barry M Wall; Adriana M Hung; Miklos Z Molnar; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-21       Impact factor: 8.237

2.  Outcomes associated with microalbuminuria: effect modification by chronic kidney disease.

Authors:  Csaba P Kovesdy; Evan H Lott; Jun Ling Lu; Sandra M Malakauskas; Jennie Z Ma; Miklos Z Molnar; Kamyar Kalantar-Zadeh
Journal:  J Am Coll Cardiol       Date:  2013-04-16       Impact factor: 24.094

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.